catalyst.phrma.orgThe Catalyst - A PhRMA Blog

Stay Connected Events Press Room Members Site Our Network About Overview Our Mission Our Leadership Members Careers Events Codes & Guidelines Advocacy Overview Access to Medicines Overview Insurance Coverage Medicare Access Better Coverage Patient Assistance Medicaid 340B Drug Pricing Program Cost & Value of Medicines Let's Talk About Cost Discounts International Intellectual Property Medicare Overview Part B Part D Center for Medicare And Medicaid Innovation Medicine Safety Overview Prescription Drug Misuse, Abuse & Disposal Drug Importation Drug Shortages Research & Development Overview Biologics & Biosimilars Clinical Trials Venture Capital FDA Modernization PDUFA Pediatrics Rare Diseases Regulatory Harmonization Vaccines The Value Collaborative 340B Science Overview Progress Treating Disease In the Pipeline Overview Medicines in Development Research in Your Backyard Clinical Trials People Behind the Science Patients Overview How Are Your Medicines Covered? Get Help With Your Prescriptions Access Patient Resources Resources State Map Press Room Resource Library Chart Packs Industry Profile 2019 Blog About Overview Our Mission Our Leadership Members Careers Events Codes & Guidelines Advocacy Overview Access to Medicines Overview Insurance Coverage Medicare Access Better Coverage Patient Assistance Medicaid 340B Drug Pricing Program Cost & Value of Medicines Intellectual Property Medicare Overview Part B Part D Center for Medicare And Medicaid Innovation Independent Payment Advisory Board Medicine Safety Overview Prescription Drug Misuse, Abuse, & Disposal Importation & Counterfeits Drug Shortages & Supply Chain Info Research & Development Overview FDA Modernization PDUFA Biologics & Biosimilars Regulatory Harmonization Clinical Trials The Value Collaborative 340B Science Overview Progress Treating Disease In the Pipeline Overview Medicines in Development Research in Your Backyard Clinical Trials People Behind the Science Patients Overview How Are Your Medicines Covered? Get Help With Your Prescriptions Hear From Patients Like You Access Patient Resources Share the Savings Resources Resource Library State Map Chart Packs Blog Stay Connected Events Pressroom Members Our Network X Search the PhRMA Network X Stay Connected Sign Up for Updates Welcome to the future of medicine. Where together, we go boldly. LEARN MORE PPA strives to improve patient health, advance medical innovation and fuel economic growth. LEARN MORE The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development. LEARN MORE Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines. LEARN MORE Learn more about America's biopharmaceutical companies and how they seek to improve patients' lives. LEARN MORE We Work For Health aims to increase awareness by uniting workers throughout the industry. LEARN MORE Patent protection should always be considered by an inventor during the initial stages of their invention. LEARN MORE Working to spread awareness and education about the importance of secure drug disposal. LEARN MORE Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions. LEARN MORE There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability. LEARN MORE About PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Policy Solutions | PhRMA Industry Profile 2019 | PhRMA Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. 340B | PhRMA Part B | PhRMA Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. The 20-year journey yielding a new weapon against cancer | PhRMA Stopping the Spread of Ebola | PhRMA Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Share the Savings | PhRMA Patient-Focused Drug Development | PhRMA Resources Explore the Resource Library, the interactive State Map and the Chart Pack reports. Press Room | PhRMA Chart Packs | PhRMA We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you. Guest Post: Amgen Foundation stands for equal opportunities in STEM learning By Guest Contributor | August 24, 2020 Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest... Read More The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development By Tom Wilbur | August 24, 2020 America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient... Read More Summer reading in the age of COVID-19 By Andrew Powaleny | August 21, 2020 As the summer of 2020 starts to creep to a close, America’s biopharmaceutical research companies are working around the clock to identify new treatments to reduce COVID-19 infection and vaccines,... Read More Systemic racism is as real as any disease, and our industry is not immune By Courtney Christian | August 20, 2020 This month, PhRMA published our commitment to racial equity and inclusion in the New York Times as well as in the Informer and the AfroAmerican, DC-based, Black-owned newspapers. This public... Read More Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually By Gabby Migliara | August 19, 2020 A recent analysis by IQVIA shows that chronically ill patients who used manufacturer cost-sharing assistance in 2019 saved hundreds to thousands of dollars on their out-of-pocket costs. IQVIA... Read More Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas By Gabby Migliara | August 12, 2020 According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of... Read More Supporting access to vaccines for Part D beneficiaries By Tom Wilbur | August 12, 2020 Today, in honor of National Immunization Awareness Month, we’ll take a look at how Medicare Part D supports access to critical vaccines and strengthens public health. Vaccines represent some of... Read More The patient perspective navigating COVID-19 By Andrew Powaleny | August 11, 2020 As PhRMA members work around the clock to combat COVID-19, the pandemic has had a tremendous impact around the globe. But for those patients who are currently impacted by a health care condition,... Read More Commercial health plans’ transition from copays to coinsurance and deductibles has increased patient out-of-pocket costs for brand medicines By Gabby Migliara | August 6, 2020 A decade ago, most patients paid only copays for brand medicines. But in recent years, use of deductibles and coinsurance in commercial health plans has skyrocketed. According to a recent IQVIA... Read More Four things to know about the IQVIA “Medicine Spending and Affordability in the U.S.” report By Katie Koziara | August 5, 2020 Today, IQVIA released a new report, Medicine Spending and Affordability in the U.S., providing context on medicine price and ...